PrECOG

NCT07285239

Phase 3, Recruiting, 2026, 500 people, 16 Dec 2025, clinicaltrials.gov

DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma

Phase 3, Completed, 2021, 214 people, 6 Apr 2020, clinicaltrials.gov

NCT04215146

Collaborator, Phase 2, Active, not recruiting, 2020, 48 people, 2 Jan 2020, clinicaltrials.gov

NCT03834688

Phase 2, Completed, 2020, 33 people, 8 Feb 2019, clinicaltrials.gov

NCT03323151

Phase 1/2, Completed, 2018, 43 people, 26 Oct 2017, clinicaltrials.gov

NCT02947685

Collaborator, Phase 3, Active, not recruiting, 2017, 518 people, 28 Oct 2016, clinicaltrials.gov

NCT02513394

Collaborator, Phase 3, Active, not recruiting, 2015, 5,796 people, 31 Jul 2015, clinicaltrials.gov

NCT01797120

Phase 2, Completed, 2013, 131 people, 22 Feb 2013, clinicaltrials.gov

NCT00790842

Phase 1/2, Terminated, 2009, 63 people, 14 Nov 2008, clinicaltrials.gov

NCT00687297

Phase 2, Completed, 2008, 162 people, 30 May 2008, clinicaltrials.gov